Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-01-16
1986-09-02
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544336, 544409, 544407, C07D24116, C07D24124, A61K 31495
Patent
active
046096590
ABSTRACT:
2,6-Disubstituted derivatives of 3-nitropyrazine are disclosed to have activity in increasing the sensitivity of tumor cells to radiation. Also disclosed are methods of preparing such compounds and pharmaceutical compositions including such compounds.
REFERENCES:
patent: 3541093 (1970-11-01), Tull et al.
patent: 3660397 (1972-05-01), Jones et al.
patent: 4414215 (1983-11-01), Hartmann
patent: 4416882 (1983-11-01), Hartmann
patent: 4418062 (1983-11-01), Hartmann
Derwent Abstract 70-15335R, Derwent Class B02, "5-Substd-Amino-6-Chloro(1H)Imidazo(4,5-6)Pyrazine-2-ones . . . ".
Hartman, et al, Mutation Research, 117, (1983), pp. 271-277.
Arther Thomas E.
Daus Donald G.
Merck & Co. , Inc.
Pfeiffer Hesna J.
Teoli, Jr. William A.
LandOfFree
2,6-disubstituted derivatives of 3-nitropyrazines useful as adju does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,6-disubstituted derivatives of 3-nitropyrazines useful as adju, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-disubstituted derivatives of 3-nitropyrazines useful as adju will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097791